Pharmafile Logo

Virtual Journal Clubs & Case Studies – Engaging Your Advisors Creatively

Creatively engage your advisors while deepening medical understanding! Dive into virtual journal clubs and case studies to analyze patient scenarios, dissect new research, and gain critical feedback on your brand and competitive landscape. It’s medical education and strategic insights combined.

Uncover real-world treatment insights and deepen medical understanding. Explore how virtual journal clubs and case study discussions can revolutionize how you engage your advisors. Learn how to facilitate rich discussions on patient cases, analyze treatment approaches, and critique scientific articles. It’s an effective way to gather critical feedback on your brand, understand the competitive landscape, and provide valuable medical education, all while fostering dynamic advisor engagement.

Virtual Journal Clubs and Case Study Discussions

  • Explore advisors’ treatment approaches for specific patient populations through online case studies.
  • Determine factors influencing treatment decisions and choices between therapies.
  • Facilitate educational opportunities through case-based discussions.
  • Conduct virtual journal clubs to annotate and discuss new articles, gaining feedback on data and competitive insights.

For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/

Learn more about Impetus Digital’s solutions: www.impetusdigital.com

Schedule a consultation: https://meetwithimpetus.com/

Stay connected:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Increased Timeliness for yor Advisory Boards

We've broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #3. Increased Timeliness to Insight-gathering and Output Delivery Based on...

Ten ways to start (or continue) your patient engagement journey

Here are 10 easy approaches Pharma teams can take when starting (or continuing) their patient engagement journey!

Increased Timeliness to Insight-gathering and Output Delivery in Virtual Advisory Boards

We've broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #3. Increased Timeliness to Insight-gathering and Output Delivery Based on...

Top 10 benefits of virtual advisory boards: Increased Engagement and Insights

#2. Increased Advisor Engagement and Quality and Quantity of Insights

Top 10 benefits of virtual advisory boards: Save Time and Resources

We've broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #1. Countless Hours of Time-savings and Substantially Reduced Costs We’ll...

10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Strengths and Weaknesses of Your Product

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Messaging and Branding

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Key Brand Attributes

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's the first one to keep...

Top 10 Most Important Advisor Questions: Unmet Needs

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's the first one to keep...